Trade AbbVie ^ABBV

AbbVie (NYSE:ABBV) Trading 2% Higher Following Analyst Upgrade

AbbVie (ABBV) One Off US$5.0b Loss Tests Bullish High P/E Valuation Narratives

Prime Capital Investment Advisors LLC Buys 3,759 Shares of AbbVie Inc. $ABBV - Markets Daily

Machina Capital S.A.S. Has $356,000 Holdings in AbbVie Inc. $ABBV

AbbVie (NYSE:ABBV) Issues Quarterly Earnings Results - Stock Observer

Top Medical Stocks To Add to Your Watchlist - February 4th - Stock Observer

AbbVie's Prognosis: The February Dip Looks Like a Buy Signal | Investing.com

Best Pharmaceutical Stocks To Watch Today - February 5th - Stock Observer

AbbVie Inc. (NYSE:ABBV) Q4 2025 Earnings Call Transcript

AbbVie Inc. $ABBV Shares Purchased by Howe & Rusling Inc. - Markets Daily

AbbVie Inc. $ABBV Shares Bought by ABN AMRO Bank N.V.

AbbVie Inc. $ABBV Stock Position Reduced by Homestead Advisers Corp

HORAN Wealth LLC Boosts Stock Holdings in AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Shares Sold by Bessemer Group Inc.

AbbVie (NYSE:ABBV) Price Target Raised to $270.00 - Stock Observer

AbbVie Earnings: Skyrizi Holds Steady Share Despite Competition | Morningstar Canada

AbbVie Q4 Earnings Call Highlights | MarketBeat

Triglav Investments D.O.O. Purchases 28,700 Shares of AbbVie Inc. $ABBV - Daily Political

AbbVie (NYSE:ABBV) Shares Down 3.8% - Here's What Happened

AbbVie Inc (ABBV) Q4 2025 Earnings Call Highlights: Record Revenues and Strategic Growth Plans

AbbVie (NYSE:ABBV) Issues Q1 2026 Earnings Guidance - Stock Observer

AbbVie (NYSE:ABBV) Announces Earnings Results, Misses Estimates By $0.66 EPS

AbbVie (NYSE:ABBV) Shares Gap Down After Earnings Miss

AbbVie (ABBV) Stock: Why Shares Are Falling Despite Earnings Beat and Strong 2026 Guidance

AbbVie Reports Full-Year and Fourth-Quarter 2025 Financial R

AbbVie forecasts 2026 profit above estimates on strong sales of newer immunology drugs

AlphaQuest LLC Trims Stock Position in AbbVie Inc. $ABBV

AbbVie (NYSE:ABBV) Issues FY 2026 Earnings Guidance - Daily Political

Savant Capital LLC Has $42.96 Million Holdings in AbbVie Inc. $ABBV

AbbVie Guides FY26 Adj. EPS Above Estimates; Q4 Results Top Estimates

AbbVie Q4 25 Earnings Conference Call At 9:00 AM ET

AbbVie News | Markets Insider

Envestnet Asset Management Inc. Reduces Position in AbbVie Inc. $ABBV - Daily Political

Savant Capital LLC Purchases 13,839 Shares of AbbVie Inc. $ABBV - Daily Political

Indolent primary cutaneous B-cell lymphomas resemble persistent antigen reactions without signs of dedifferentiation

Repotrectinib in NTRK fusion-positive advanced solid tumors: a phase 1/2 trial

Pharmaceutical Stocks To Watch Now - February 3rd - Markets Daily

Jim Cramer Says "I Like AstraZeneca Very Much"

AbbVie Targets Post Humira Growth With Cell Therapy And RINVOQ Expansion

Pettee Investors Inc. Trims Stake in AbbVie Inc. $ABBV

What Does Wall Street Think About AbbVie Inc. (ABBV)?

AbbVie Inc. $ABBV Shares Sold by Sollinda Capital Management LLC - Stock Observer

AbbVie Inc. $ABBV Shares Purchased by Jones Financial Companies Lllp - Stock Observer

Elm Partners Management LLC Buys 2,609 Shares of AbbVie Inc. $ABBV - Daily Political

AbbVie (ABBV) Q4 Earnings: What To Expect

AbbVie Inc. (ABBV): A Bull Case Theory

Evaluation of c-Abl inhibitor vodobatinib in subjects with early Parkinson's disease: a phase 2, randomized, double-blind, placebo-controlled study

AbbVie (NYSE:ABBV) Trading 1.2% Higher - Time to Buy?

AbbVie's Shift Beyond Humira With Skyrizi and Rinvoq Might Change The Case For Investing In AbbVie (ABBV)

Best Pharmaceutical Stocks To Watch Today - February 1st - Markets Daily

Guerra Advisors Inc Increases Stake in AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Shares Sold by AGF Management Ltd.

United Community Bank Has $2.39 Million Holdings in AbbVie Inc. $ABBV - Markets Daily

United Community Bank Has $2.39 Million Stake in AbbVie Inc. $ABBV - Stock Observer

Medical Stocks To Keep An Eye On - February 1st - Markets Daily

AbbVie's US$100b Drug Pricing Pact Reshapes Growth And Policy Outlook

Top Pharmaceutical Stocks To Add to Your Watchlist - January 31st - Markets Daily

AbbVie Inc. $ABBV Shares Bought by Donaldson Capital Management LLC - Markets Daily

Government Exempts Customs Duty on 17 Critical Cancer Drugs to Alleviate Patient Costs, ETPharma

AbbVie Inc. $ABBV Shares Sold by Transcend Capital Advisors LLC

AbbVie Inc. $ABBV Shares Purchased by Thrivent Financial for Lutherans - Markets Daily

AbbVie Inc. $ABBV Shares Bought by Atle Fund Management AB

AbbVie Inc. $ABBV is Donaldson Capital Management LLC's 6th Largest Position - Stock Observer

Thrivent Financial for Lutherans Acquires 34,384 Shares of AbbVie Inc. $ABBV - Stock Observer

Citi Sees a More Supportive Backdrop Forming for AbbVie (ABBV) and Biopharma

AbbVie Inc. $ABBV Stake Decreased by Keybank National Association OH

National Pension Service Raises Stock Position in AbbVie Inc. $ABBV

AbbVie's US$100b Pledge Raises Questions On Value, Margins And Debt

L.M. Kohn & Company Decreases Stock Position in AbbVie Inc. $ABBV - Daily Political

AbbVie Links U.S. Investment Pledge And Pricing Shift To Cancer Pipeline

AbbVie (NYSE:ABBV) Trading 1.2% Higher - What's Next? - Daily Political

Townsquare Capital LLC Sells 7,540 Shares of AbbVie Inc. $ABBV

Banyan Capital Management Inc. Takes Position in AbbVie Inc. $ABBV - Markets Daily

Alpha Cubed Investments LLC Raises Stock Position in AbbVie Inc. $ABBV

Banyan Capital Management Inc. Takes Position in AbbVie Inc. $ABBV - Stock Observer

Citigroup Cuts AbbVie (NYSE:ABBV) Price Target to $230.00 - Daily Political

AbbVie's US Pricing Deal Reframes Growth Prospects And R&D Commitments - Simply Wall St News

TD Waterhouse Canada Inc. Has $26.55 Million Stock Position in AbbVie Inc. $ABBV - Markets Daily

Great Lakes Advisors LLC Decreases Stock Holdings in AbbVie Inc. $ABBV

AE Wealth Management LLC Acquires 18,651 Shares of AbbVie Inc. $ABBV

New York State Common Retirement Fund Sells 129,300 Shares of AbbVie Inc. $ABBV - Daily Political

AbbVie Inc. $ABBV Stock Holdings Lifted by Fidelis Capital Partners LLC - Stock Observer

Novo Nordisk's Massive Advertising Spend on Wegovy and Ozempic Surpasses Eli Lilly's by 2x in 2025, ETPharma

Why AbbVie Stock Trounced the Market in 2025

AbbVie (NYSE:ABBV) Stock Price Down 2.2% on Analyst Downgrade

Is AbbVie (ABBV) Pricing Reflect Its DCF And Price To Sales Signals After Recent Gains

AbbVie's Irish operations in firing line as Trump targets Botox prices

AbbVie Inc. $ABBV Shares Bought by Mirae Asset Global Investments Co. Ltd.

AbbVie (NYSE:ABBV) Shares Down 2.2% on Analyst Downgrade - Daily Political